Your browser doesn't support javascript.
Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.
Kurian, Christine J; French, Zachary; Kukulich, Patrick; Lankiewicz, Matthew; Ghimire, Sushil; Maarouf, Omar H; Rizk, Sanaa; Rhoades, Ruben.
  • Kurian CJ; Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA. xtine.kurian@gmail.com.
  • French Z; Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
  • Kukulich P; Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
  • Lankiewicz M; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Ghimire S; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Maarouf OH; Department of Medicine, Division of Nephrology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Rizk S; Department of Medicine, Division of Hematology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Rhoades R; Department of Medicine, Division of Hematology, Thomas Jefferson University, Philadelphia, PA, USA.
J Med Case Rep ; 15(1): 587, 2021 Dec 13.
Article in English | MEDLINE | ID: covidwho-1571927
ABSTRACT

BACKGROUND:

Atypical hemolytic uremic syndrome is an exceedingly rare thrombotic microangiopathy caused by accelerated activation of the alternative complement pathway. CASE PRESENTATION Here, we report two cases of patients presenting with suspected atypical hemolytic uremic syndrome precipitated by coronavirus disease 2019 infection. The first patient, a 25-year-old Hispanic male, had one prior episode of thrombotic microangiopathy presumed to be atypical hemolytic uremic syndrome precipitated by influenza A, and re-presented with thrombocytopenia, microangiopathic hemolytic anemia, nonoliguric renal failure, and normal ADAMTS13 activity, with confirmed coronavirus disease 2019 positivity. The second patient, a 31-year-old Caucasian female, had no personal history of thrombotic microangiopathy, though reported a family history of suspected atypical hemolytic uremic syndrome. She presented with similar laboratory derangements, oliguric renal failure requiring hemodialysis, and confirmed coronavirus disease 2019 positivity. Both patients were treated with eculizumab with complete resolution of their hematologic and renal complications.

CONCLUSION:

To our knowledge, this represents the largest case series of atypical hemolytic uremic syndrome precipitated by coronavirus disease 2019 in adults.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Thrombotic Microangiopathies / Atypical Hemolytic Uremic Syndrome / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Female / Humans / Male Language: English Journal: J Med Case Rep Year: 2021 Document Type: Article Affiliation country: S13256-021-03144-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / Thrombotic Microangiopathies / Atypical Hemolytic Uremic Syndrome / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Female / Humans / Male Language: English Journal: J Med Case Rep Year: 2021 Document Type: Article Affiliation country: S13256-021-03144-2